Elif Bahat Özdoğan

Elif Bahat Özdoğan

Auto-generated profile, based on publicly available information

Elif Bahat Özdoğan

Department of Pediatrics, Division of Pediatric Nephrology, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Pediatrics & Neonatology
Verified
Journal Article
Open access
EOElif Bahat Ozdogan
Elif Bahat Ozdogan
MMMehmet Mutlu
Mehmet Mutlu
SCSecil Arslansoyu Camlar
Secil Arslansoyu Camlar
GBGülcin Bayramoglu
Gülcin Bayramoglu
SKSebnem Kader
Sebnem Kader
YAYakup Aslan
Yakup Aslan
It is controversial to test for urinary tract infection (UTI) in patients with unexplained indirect hyperbilirubinemia in the first 2 weeks of life. We aimed to study the prevalence and significance of UTIs in such neonates who were requiring phototherapy. Subjects were 2- to 14-day-old neonates with indirect bilirubin levels above phototherapy limit with no other abnormality in their bilirubinaemia-related etiologic workup. UTI was diagnosed by 2 consecutive positive cultures obtained by catheterisation, documenting growth of >10,000 colonies of the same microorganism with consistent antibiograms. The UTI (+) patients were evaluated by renal ultrasonography (US), and some were followed up for possible recurrent UTI. 262 neonates were included in the study. UTI prevalence was 12.2%, and bacteraemia was 6.2% among UTI (+) patients. The two most common pathogens (81.2%) were Escherichiacoli and Klebsiella. pneumonia. All UTI (+) patients had undergone US, revealing 12.5% pelvicaliectasis, other 12.5% increased renal parenchymal echogenicity, 3.1% concurrent pelvicaliectasis and increased renal parenchymal echogenicity. 53.1% of UTI (+) patients had undergone follow-up, after which 23.5% recurrent UTI were found at the end of a mean of 52 months. We suggest that the neonates with unexplained pathological jaundice should be tested for possible UTI. Consequently, all newborns with UTI shall be evaluated by the urinary US and followed up for recurrent UTI.

3 July 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
EÖElif Bahat Özdoğan
Elif Bahat Özdoğan
TÖTuğba Özdemir
Tuğba Özdemir
SÇSeçil Arslansoyu Çamlar
Seçil Arslansoyu Çamlar
MIMustafa Imamoğlu
Mustafa Imamoğlu
ÜÇÜmit Çobanoğlu
Ümit Çobanoğlu
İDİsmail Doğan
İsmail Doğan
Objectives.This study aimed to demonstrate if the addition of anti-inflammatory treatment to antibiotic therapy shows any superiority to the treatment with antibiotic only.Methods.Forty-nine Wistar rats were divided into 7 groups. Pyelonephritis was performed byE. coliinjection to upper pole of kidneys except control group. Group 2 was not treated. Ceftriaxone, ketoprofen, “ceftriaxone + ketoprofen,” methylprednisolone, and “ceftriaxone + methylprednisolone” were given in the groups. The technetium-99m-dimercaptosuccinic acid scintigraphies were performed in 3rd day to detect pyelonephritis and 10th week to detect renal scarring. All kidneys were also histopathologically evaluated.Results.When 3rd day and 10th week scintigraphies were compared, initial 2.00 ± 0.30 point pyelonephritis score resulted in 0.71 ± 0.36 renal scar score in “ceftriaxone + ketoprofen” group (P=0.039). Initial 2.00 ± 0.43 point pyelonephritis score resulted in 0.86 ± 0.26 renal scar score in “ceftriaxone + methylprednisolone” group (P=0.041). Renal scar score was declined in “ceftriaxone + ketoprofen” group and “ceftriaxone + methylprednisolone” group compared with no-treatment group on 10th week of the study (P=0.026,P=0.044). On histopathological evaluation, it was seen that renal scar prevalence and expansion declined significantly in “ceftriaxone + ketoprofen and ceftriaxone + methylprednisolone” (P=0.011,P=0.023).Conclusion.It was evidenced that ceftriaxone treatment in combination with ketoprofen or methylprednisolone declined scar formation in scintigraphic and histopathologic examinations of the kidneys.

24 November 2014 in Canadian Urological Association Journal
Verified
Journal Article
Open access
PDF file
EÖElif Bahat Özdoğan
Elif Bahat Özdoğan
ŞTŞükran Tıraş
Şükran Tıraş
SÇSeçil Arslansoyu Çamlar
Seçil Arslansoyu Çamlar
MIMustafa Imamoğlu
Mustafa Imamoğlu
ACAyşegül Cansu
Ayşegül Cansu
SBSevcan Bilen
Sevcan Bilen
Eosinophilic cystitis is a rare inflammatory disease of the bladder; it rarely occurs in children. Patients typically show irritative urination symptoms frequently, with a possible need for urgency, alongside dysuria, gross hematuria, suprapubic pain and painful urination. Sometimes bladder mass accumulation with the possibility of malignancy is also observed. We present an 8-year-old male patient who gained admission for terminal hematuria and discuss the management of eosinophilic cystitis.

21 October 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
DADilara Atasoy
Dilara Atasoy
ACAyşegül CANSU
Ayşegül CANSU
ABAyşe Füsun Bekirçavuşoğlu
Ayşe Füsun Bekirçavuşoğlu
EÖElif Bahat Özdoğan
Elif Bahat Özdoğan
AAAli Ahmetoğlu
Ali Ahmetoğlu
Backgroun/Aim: The presented study aimed to evaluate the utility of Magnetic Resonance Angiography in the pediatric population with nutcracker syndrome. Patients with suggestive clinical symptoms and laboratory findings and got the diagnosis of nutcracker syndrome with Doppler ultrasonography between January 2011-2019 were included in the study. In addition, children who had renal MRA due to hypertension were evaluated as the control group. MRA images of all patients were examined retrospectively by 3 radiologists at different levels of experience, and the superior mesenteric artery angle, aorta-mesenteric distance, left renal vein diameter both in the regions of aorta-mesenteric and renal hilum were recorded. Forty-five patients diagnosed with nutcracker syndrome were included in the study. The mean age of patients was 12 (4-16) and 30 (67%) were female. As the control group, 25 patients with hypertension who had MRA were included and they had a mean age of 12 (1-18) and 19 (76%) were male. The mean superior mesenteric artery angle was 26.5 ° (16-73 ± 12) in the patient group and 57.8 ° (25-139, ± 33) in the control group (p <0.001); the mean aorta-mesenteric distance was 3.3 mm (1.7-6.5, ± 1.1) in the patient group and 8 mm (3.4-32, ± 5.9) in the control group (p <0.001). MRA measurements of 3 radiologists were consistent with each other. MRA imaging can be applied as an alternative diagnostic method for Doppler ultrasonography and Multidetector CT examinations by radiologists with different experience levels in pediatric patients with nutcracker syndrome.

1 March 2007 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
EBElif Bahat
Elif Bahat
BABahar Kilicarslan Akkaya
Bahar Kilicarslan Akkaya
SASema Akman
Sema Akman
GKGulten Karpuzoglu
Gulten Karpuzoglu
AGAyfer Gur Guven
Ayfer Gur Guven
Background: There has been no controlled study comparing efficacy of pulse versus oral steroid therapy in childhood membranoproliferative glomerulonephritis (MPGN). This study aimed to compare these therapies and renal outcome over a long-term period for MPGN. Methods: Outcome measures in 11 patients with MPGN treated with pulse methylprednisolone (MP) were compared with 8 patients with MPGN treated with oral prednisolone (P). Results: Nineteen children with idiopathic MPGN (mean age 9.75 years, range 3.7-14 years) were followed for a mean period of 68.21 months (range 4-124 months). Both treatment groups were similar in demographic, clinical, laboratory and histopathological characteristics on presentation. In the pulse MP group, only 1 patient out of 11 progressed to end-stage renal failure (ESRF), compared with 4 patients out of 8 in the oral P group (p=0.041). For longterm renal survival, those patients with more than 8 years of follow-up were further evaluated. Twelve patients had completed 8 years of follow-up; in the pulse MP group, 1 of 7 patients, compared with 4 of 5 patients in the oral P group progressed to ESRF (p=0.039). Chronic damage in the presentation biopsy and lack of remission in patients with nephrotic syndrome (NS) were positively associated with adverse renal outcome (p=0.02, p=0.006, respectively). Conclusions: Pulse MP therapy may be superior to oral P therapy in children with MPGN in preserving renal function without any increase in steroid-related side effects. Chronic damage in the presentation biopsy and lack of remission of NS are adverse features.

29 September 2020 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
ESElif Sağ
Elif Sağ
BGBurcu Güven
Burcu Güven
HYHatice Sonay Yalçın
Hatice Sonay Yalçın
IEİlKer Eyüpoğlu
İlKer Eyüpoğlu
AÇAlper Han Çebi̇
Alper Han Çebi̇
EÖElif Bahat Özdoğan
Elif Bahat Özdoğan
AMAÇ: Karaciğerin fibrokistik hastalıkları (KFKH); intrahepatik ve/veya ekstrahepatik biliyer anormallikler sonucunda safra kanallarında genişleme, hepatik fibrozis ve kistik oluşumlarla karakterize olan kalıtsal geçişli nadir görülen bir hastalık grubudur. Hastalar asemptomatik olabileceği gibi kolanjit, portal hipertansiyon, siroz, ele gelen kitle gibi semptomlarla başvurabilirler. Çalışmamızda; kliniğimizde takipli, KFKH olan hastaları; demografik özellikleri, klinik-laboratuvar bulguları ve son durumları ile değerlendirdik.GEREÇ VE YÖNTEMLER: Çalışmamıza; Ocak 2008- Aralık 2019 yılları arasında, Çocuk Gastroenteroloji, Hepatoloji ve Beslenme polikliniğinde KFKH nedeniyle takipli olan hastalar; klinik-laboratuvar bulguları, tedavi yaklaşımları ve son durumları ile geriye dönük olarak incelendi.BULGULAR: Toplam 39 hasta incelendi (%56.4 erkek, ortanca yaş; 5 yıl 3 ay, yaş aralığı: 1 ay-16.8 yıl). Sekiz hastada (%20.5) Caroli hastalığı (CH), 16 hastada konjenital hepatik fibrozis (KHF) (%41), 15 hastada koledok kisti tespit edilmişti. Başvuru şikayeti; en sık sarılık (n=8, %20.5), kronik karın ağrısı (n=6, %15.4) ve splenomegali (n=4, %10.3) idi. Sekiz hasta renal kist tespiti sonrası taramada (%20.5), yedi hasta intrauterin dönemde (%17.9), iki hasta ise insidental olarak tespit edilmişti (%5.1). Otozomal resesif polikistik böbrek hastalığı (ORPBH) olan altı hastada PKHD1 gen mutasyonu saptandı. On sekiz hasta opere edildi (%46.2, karaciğer nakli, sol lol segmental hepatektomi, mezokaval şant, böbrek nakli, kistektomi). 25 hastaya (%64.1) eşlik eden başka hastalıklar mevcuttu; 18’inde (%46.2) ORPBH, ikisinde metal motor retardasyon (%5.1; birinde metokromatik lökodistrofi, diğerinde Arnold Chiari malformasyonu), birer hastada (%2.6) nefrokalsinozis, juvenil nefronofitizis (böbrek nakli), akut pankreatit, pulmoner-metakarpal distal falanks hipoplazisi ve birinde medüler sünger böbrek ve pineal kist mevcuttu. Takip edilen 39 hastanın altısında portal hipertansiyon, beşinde kronik böbrek yetmezliği (%12.8), dördünde kompanse kronik karaciğer hastalığı (%10.3) ve birinde tekrarlayan kolanjit atakları (%2.6) olup CH olan bir hastaya dekompanse siroz nedeniyle karaciğer nakli yapılmıştı.TARTIŞMA: Karaciğerin fibrokistik hastalıkları; morbiditesi ve ileri dönem komplikasyon riski yüksek olan bir hastalık olması nedeniyle erken tanı konup düzenli takip yapılmalıdır.